1. Home
  2. BNTC vs SES Comparison

BNTC vs SES Comparison

Compare BNTC & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • SES
  • Stock Information
  • Founded
  • BNTC 1995
  • SES 2012
  • Country
  • BNTC United States
  • SES United States
  • Employees
  • BNTC N/A
  • SES N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • SES Auto Parts:O.E.M.
  • Sector
  • BNTC Health Care
  • SES Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • SES Nasdaq
  • Market Cap
  • BNTC 366.6M
  • SES 370.5M
  • IPO Year
  • BNTC N/A
  • SES N/A
  • Fundamental
  • Price
  • BNTC $14.42
  • SES $0.84
  • Analyst Decision
  • BNTC Strong Buy
  • SES Hold
  • Analyst Count
  • BNTC 6
  • SES 3
  • Target Price
  • BNTC $23.83
  • SES $1.50
  • AVG Volume (30 Days)
  • BNTC 72.3K
  • SES 9.7M
  • Earning Date
  • BNTC 05-14-2025
  • SES 07-28-2025
  • Dividend Yield
  • BNTC N/A
  • SES N/A
  • EPS Growth
  • BNTC N/A
  • SES N/A
  • EPS
  • BNTC N/A
  • SES N/A
  • Revenue
  • BNTC N/A
  • SES $7,833,000.00
  • Revenue This Year
  • BNTC N/A
  • SES $916.42
  • Revenue Next Year
  • BNTC N/A
  • SES $151.67
  • P/E Ratio
  • BNTC N/A
  • SES N/A
  • Revenue Growth
  • BNTC N/A
  • SES N/A
  • 52 Week Low
  • BNTC $5.74
  • SES $0.20
  • 52 Week High
  • BNTC $17.15
  • SES $2.53
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 44.90
  • SES 42.72
  • Support Level
  • BNTC $14.42
  • SES $0.94
  • Resistance Level
  • BNTC $17.10
  • SES $1.01
  • Average True Range (ATR)
  • BNTC 1.20
  • SES 0.08
  • MACD
  • BNTC -0.18
  • SES -0.02
  • Stochastic Oscillator
  • BNTC 3.66
  • SES 9.47

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.

Share on Social Networks: